| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Fatima Djouadi | Q55692134 |
| Carina Prip-Buus | Q88092873 | ||
| Arnold Munnich | Q2863363 | ||
| P2093 | author name string | Jean-Paul Bonnefont | |
| Jean Bastin | |||
| Stephanie Gobin | |||
| P433 | issue | 5-6 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 495-520 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Molecular Aspects of Medicine | Q6895933 |
| P1476 | title | Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects | |
| P478 | volume | 25 |
| Q50074816 | A Metabolic Basis for Endothelial-to-Mesenchymal Transition. |
| Q42593243 | A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency |
| Q51353851 | A common haplotype of carnitine palmitoyltransferase 1b is associated with the metabolic syndrome. |
| Q34215708 | A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia |
| Q26699142 | A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation |
| Q28544452 | Abbreviated half-lives and impaired fuel utilization in carnitine palmitoyltransferase II variant fibroblasts |
| Q40869464 | Acetyl CoA carboxylase inactivation and meiotic maturation in mouse oocytes |
| Q64249384 | Acute Effects of Single Doses of Bonito Fish Peptides and Vitamin D on Whole Blood Gene Expression Levels: A Randomized Controlled Trial |
| Q35146102 | Acyl-CoA binding proteins interact with the acyl-CoA binding domain of mitochondrial carnitine palmitoyl transferase I. |
| Q54531876 | Adipogenic gene expression and fatty acid composition in subcutaneous adipose tissue depots of Angus steers between 9 and 16 months of age. |
| Q48009070 | Alterations to mitochondrial fatty-acid use in skeletal muscle after chronic exposure to hypoxia depend on metabolic phenotype. |
| Q37676063 | Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension. |
| Q36709232 | An active metabolite of oltipraz (M2) increases mitochondrial fuel oxidation and inhibits lipogenesis in the liver by dually activating AMPK |
| Q59329323 | An altered gene expression profile in tyramine-exposed intestinal cell cultures supports the genotoxicity of this biogenic amine at dietary concentrations |
| Q80172441 | An improved enzyme assay for carnitine palmitoyl transferase I in fibroblasts using tandem mass spectrometry |
| Q36247025 | Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice |
| Q42833582 | Ashitaba (Angelica keiskei) extract prevents adiposity in high-fat diet-fed C57BL/6 mice |
| Q47231445 | Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure |
| Q37670599 | Ataluren as an agent for therapeutic nonsense suppression |
| Q46521046 | Autopsy case of the neonatal form of carnitine palmitoyltransferase-II deficiency triggered by a novel disease-causing mutation del1737C. |
| Q40316251 | Bezafibrate upregulates carnitine palmitoyltransferase II expression and promotes mitochondrial energy crisis dissipation in fibroblasts of patients with influenza-associated encephalopathy |
| Q37686246 | Bioenergetic medicine |
| Q92309074 | Bioinformatic Profiling Identifies a Fatty Acid Metabolism-Related Gene Risk Signature for Malignancy, Prognosis, and Immune Phenotype of Glioma |
| Q33708579 | Blocking of carnitine palmitoyl transferase 1 potently reduces stress-induced depression in rat highlighting a pivotal role of lipid metabolism |
| Q39287166 | CPT1A: the future of heart disease detection and personalized medicine? |
| Q40076619 | CPT2 gene mutation analysis and prenatal diagnosis in a family with carnitine palmitoyltransferase II deficiency |
| Q45953629 | CPT2 gene mutations resulting in lethal neonatal or severe infantile carnitine palmitoyltransferase II deficiency. |
| Q39471860 | Cardiac mitochondrial proteomic expression in inbred rat strains divergent in survival time after hemorrhage |
| Q46142793 | Cardiopulmonary Exercise Testing and Metabolic Myopathies |
| Q89993156 | Carnitine Inborn Errors of Metabolism |
| Q40792584 | Carnitine palmitoyl transferase 2 polymorphism may be associated with enterovirus 71 severe infection in a Chinese population |
| Q30238774 | Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data |
| Q37190404 | Carnitine palmitoyltransferase IA polymorphism P479L is common in Greenland Inuit and is associated with elevated plasma apolipoprotein A-I |
| Q90259554 | Carnitine palmitoyltransferase II deficiency with a focus on newborn screening |
| Q30487371 | Carnitine palmitoyltransferase II deficiency: successful anaplerotic diet therapy |
| Q55023687 | Carnitine palmitoyltransferase gene upregulation by linoleic acid induces CD4+ T cell apoptosis promoting HCC development. |
| Q35113488 | Central nervous system neuropeptide Y regulates mediators of hepatic phospholipid remodeling and very low-density lipoprotein triglyceride secretion via sympathetic innervation |
| Q57940190 | Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis |
| Q36160512 | Circadian and Dopaminergic Regulation of Fatty Acid Oxidation Pathway Genes in Retina and Photoreceptor Cells |
| Q37071477 | Combination of honokiol and magnolol inhibits hepatic steatosis through AMPK-SREBP-1 c pathway |
| Q35154760 | Comparative proteome analysis of brown adipose tissue in obese C57BL/6J mice using iTRAQ-coupled 2D LC-MS/MS |
| Q28578888 | Crystal structure of rat carnitine palmitoyltransferase II (CPT-II) |
| Q24607519 | Crystal structures of murine carnitine acetyltransferase in ternary complexes with its substrates |
| Q47836759 | Deciphering metabolic rewiring in breast cancer subtypes |
| Q34695413 | Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice |
| Q35625960 | Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases |
| Q36678362 | Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model |
| Q38696841 | Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences |
| Q38476306 | Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes. |
| Q38397776 | Diagnostic pitfall in antenatal manifestations of CPT II deficiency. |
| Q39511975 | Differences in metabolic biomarkers in the blood and gene expression profiles of peripheral blood mononuclear cells among normal weight, mildly obese and moderately obese subjects |
| Q45718103 | Differential developmental programming by early protein restriction of rat skeletal muscle according to its fibre-type composition. |
| Q49247394 | Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease |
| Q24658342 | Disorders of carnitine transport and the carnitine cycle |
| Q89172209 | Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle |
| Q55038844 | Downregulation of CPT2 promotes tumorigenesis and chemoresistance to cisplatin in hepatocellular carcinoma. |
| Q60912694 | Dysregulation of Lipid Metabolism in Mkp-1 Deficient Mice during Gram-Negative Sepsis |
| Q35986725 | Effect of marine omega 3 fatty acids on methylmercury-induced toxicity in fish and mammalian cells in vitro. |
| Q36018329 | Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease |
| Q37123153 | Effects of a healthy Nordic diet on gene expression changes in peripheral blood mononuclear cells in response to an oral glucose tolerance test in subjects with metabolic syndrome: a SYSDIET sub-study |
| Q98565733 | Effects of dietary terrestrial oils supplemented with L-carnitine on growth, antioxidant capacity, lipid metabolism and inflammation in large yellow croaker (Larimichthys crocea) |
| Q46118766 | Enhanced susceptibility of Cpt1c knockout mice to glucose intolerance induced by a high-fat diet involves elevated hepatic gluconeogenesis and decreased skeletal muscle glucose uptake |
| Q34980719 | Enhancing hepatic mitochondrial fatty acid oxidation stimulates eating in food-deprived mice |
| Q34406002 | Epigenome-wide association study of fasting blood lipids in the Genetics of Lipid-lowering Drugs and Diet Network study |
| Q28817847 | Epithelial magnesium transport by TRPM6 is essential for prenatal development and adult survival |
| Q30315255 | Establishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line. |
| Q36146071 | Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice |
| Q42374192 | Eugenol inhibits oxidative phosphorylation and fatty acid oxidation via downregulation of c-Myc/PGC-1β/ERRα signaling pathway in MCF10A-ras cells |
| Q64264906 | Evaluation of Metabolic Defects in Fatty Acid Oxidation Using Peripheral Blood Mononuclear Cells Loaded with Deuterium-Labeled Fatty Acids |
| Q46399354 | Examination of carnitine palmitoyltransferase 1 abundance in white adipose tissue: implications in obesity research |
| Q47299569 | Exertional rhabdomyolysis leading to acute kidney injury: when genetic defects are diagnosed in adult life |
| Q38025784 | Expanded newborn screening for inborn errors of metabolism: overview and outcomes. |
| Q37631744 | Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma. |
| Q34231924 | Expression of miR-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation |
| Q41640775 | FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone. |
| Q54234131 | Fatty acid metabolism in CD8+ T cell memory: Challenging current concepts. |
| Q26747750 | Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer |
| Q33631932 | Fatty acid synthesis and oxidation in cumulus cells support oocyte maturation in bovine |
| Q52686285 | Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency. |
| Q34331484 | Forage preservation (grazing vs. hay) fed to ewes affects the fatty acid profile of milk and CPT1B gene expression in the sheep mammary gland. |
| Q62740961 | Forms of n-3 (ALA, C18:3n-3 or DHA, C22:6n-3) Fatty Acids Affect Carcass Yield, Blood Lipids, Muscle n-3 Fatty Acids and Liver Gene Expression in Lambs |
| Q26749062 | Genetic Variation of Fatty Acid Oxidation and Obesity, A Literature Review |
| Q38039376 | Genetics and metabolic cardiomyopathies |
| Q36485619 | Genome- and epigenome-wide association study of hypertriglyceridemic waist in Mexican American families |
| Q37193633 | Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis |
| Q28548020 | HEPNet: A Knowledge Base Model of Human Energy Pool Network for Predicting the Energy Availability Status of an Individual |
| Q40104945 | Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway |
| Q40096587 | Health effects of the CPT1A P479L variant: responsible public health policy |
| Q36503299 | Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A. |
| Q57817278 | Heterogeneity of fatty acid metabolism in breast cancer cells underlies differential sensitivity to palmitate-induced apoptosis |
| Q55187995 | Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β. |
| Q38875398 | Increased expression of fatty acid synthase provides a survival advantage to colorectal cancer cells via upregulation of cellular respiration |
| Q36967938 | Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer |
| Q38019608 | Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs |
| Q46912061 | Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue |
| Q27678642 | Isothermal titration calorimetry with micelles: Thermodynamics of inhibitor binding to carnitine palmitoyltransferase 2 membrane protein |
| Q35677743 | Localization of a gene for nonsyndromic renal hypodysplasia to chromosome 1p32-33 |
| Q43053414 | Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. |
| Q52689591 | Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis. |
| Q41462386 | Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression |
| Q104465961 | Marein ameliorates Ang II/hypoxia-induced abnormal glucolipid metabolism by modulating the HIF-1α/PPARα/γ pathway in H9c2 cells |
| Q64094610 | Maternal diet deficient in riboflavin induces embryonic death associated with alterations in the hepatic proteome of duck embryos |
| Q43004760 | Medium-chain triglycerides impair lipid metabolism and induce hepatic steatosis in very long-chain acyl-CoA dehydrogenase (VLCAD)-deficient mice |
| Q57530398 | Metabolic imaging of hyperpolarized [1-13C]acetate and [1-13C]acetylcarnitine - investigation of the influence of dobutamine induced stress |
| Q64099753 | Metabolic lipid muscle disorders: biomarkers and treatment |
| Q37776434 | Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction |
| Q46026671 | Metabolomics reveals that carnitine palmitoyltransferase-1 is a novel target for oxidative inactivation in human cells. |
| Q91640990 | Mild Hypothermia Attenuates Hepatic Ischemia-Reperfusion Injury through Regulating the JAK2/STAT3-CPT1a-Dependent Fatty Acid β-Oxidation |
| Q40719444 | Missed Newborn Screening Case of Carnitine Palmitoyltransferase-II Deficiency |
| Q46359827 | Mitochondria and Angiogenesis |
| Q64943955 | Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies. |
| Q37744748 | Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening |
| Q39280722 | Mitochondrial miRNAs in diabetes: just the tip of the iceberg |
| Q37727871 | Modified SJH alleviates FFAs-induced hepatic steatosis through leptin signaling pathways |
| Q28573526 | Modulation of the hepatic malonyl-CoA-carnitine palmitoyltransferase 1A partnership creates a metabolic switch allowing oxidation of de novo fatty acids |
| Q53589148 | Molecular assay for detection of the common carnitine palmitoyltransferase 1A 1436(C>T) mutation. |
| Q36958324 | Molecular mechanisms of statin intolerance |
| Q30313571 | Muscle Carnitine Palmitoyltransferase II Deficiency: A Review of Enzymatic Controversy and Clinical Features |
| Q39610485 | Neonatal carnitine palmitoyltransferase II deficiency associated with Dandy-Walker syndrome and sudden death. |
| Q55078234 | Neonatal tobacco smoke reduces thermogenesis capacity in brown adipose tissue in adult rats. |
| Q37107797 | New insight into the role of MMP14 in metabolic balance |
| Q24679531 | New insights concerning the role of carnitine in the regulation of fuel metabolism in skeletal muscle |
| Q55002742 | Nordihydroguaiaretic Acid, a Lignan from Larrea tridentata (Creosote Bush), Protects Against American Lifestyle-Induced Obesity Syndrome Diet-Induced Metabolic Dysfunction in Mice. |
| Q41861654 | Normal Levels of Plasma Free Carnitine and Acylcarnitines in Follow-Up Samples from a Presymptomatic Case of Carnitine Palmitoyl Transferase 1 (CPT1) Deficiency Detected Through Newborn Screening in Denmark. |
| Q36768639 | Novel Mutations in the CPT1A Gene Identified in the Patient Presenting Jaundice as the First Manifestation of Carnitine Palmitoyltransferase 1A Deficiency |
| Q90308915 | Novel metabolic disorders in skeletal muscle of Lipodystrophic Bscl2/Seipin deficient mice |
| Q64252273 | Nuclear Peroxisome Proliferator-Activated Receptors (PPARs) as Therapeutic Targets of Resveratrol for Autism Spectrum Disorder |
| Q90427915 | PAS Kinase deficiency alters the glucokinase function and hepatic metabolism |
| Q65002909 | PGC1α/CEBPB/CPT1A axis promotes radiation resistance of nasopharyngeal carcinoma through activating fatty acid oxidation. |
| Q37130100 | PPARs as therapeutic targets for correction of inborn mitochondrial fatty acid oxidation disorders |
| Q38711026 | PPARα regulates tumor cell proliferation and senescence via a novel target gene carnitine palmitoyltransferase 1C. |
| Q37096266 | Palmitic acid and DGAT1 deficiency enhance osteoclastogenesis, while oleic acid-induced triglyceride formation prevents it |
| Q38357539 | Peroxisome-mitochondria interplay and disease. |
| Q92863867 | Physiological aspects of muscular adaptations to training translated to neuromuscular diseases |
| Q35613008 | Post-treatment with the combination of 5-aminoimidazole-4-carboxyamide ribonucleoside and carnitine improves renal function after ischemia/reperfusion injury |
| Q26853485 | Powering the immune system: mitochondria in immune function and deficiency |
| Q90781951 | Preconception carrier screening yield: effect of variants of unknown significance in partners of carriers with clinically significant variants |
| Q36014621 | Protection from Metabolic Dysregulation, Obesity, and Atherosclerosis by Citrus Flavonoids: Activation of Hepatic PGC1α-Mediated Fatty Acid Oxidation |
| Q38369733 | Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins |
| Q37716673 | Reliable Diagnosis of Carnitine Palmitoyltransferase Type IA Deficiency by Analysis of Plasma Acylcarnitine Profiles |
| Q35787531 | Replacement of Dietary Saturated Fat by PUFA-Rich Pumpkin Seed Oil Attenuates Non-Alcoholic Fatty Liver Disease and Atherosclerosis Development, with Additional Health Effects of Virgin over Refined Oil |
| Q26748160 | Resveratrol and Myopathy |
| Q38190550 | Rhabdomyolysis and Cardiomyopathy in a 20-Year-Old Patient with CPT II Deficiency. |
| Q96135049 | Rhabdomyolysis caused by carnitine palmitoyltransferase 2 deficiency: A case report and systematic review of the literature |
| Q39385165 | S6K1 determines the metabolic requirements for BCR-ABL survival. |
| Q47155178 | STAMP2 is required for human adipose-derived stem cell differentiation and adipocyte-facilitated prostate cancer growth in vivo |
| Q47959167 | Severe Hyperammonemic Encephalopathy Requiring Dialysis Aggravated by Prolonged Fasting and Intermittent High Fat Load in a Ramadan Fasting Month in a Patient with CPTII Homozygous Mutation |
| Q38260931 | Single-nucleotide polymorphisms and DNA methylation markers associated with central obesity and regulation of body weight. |
| Q30315201 | Stabilization of the thermolabile variant S113L of carnitine palmitoyltransferase II. |
| Q34580810 | State of the art in muscle lipid diseases |
| Q40528109 | Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts |
| Q36177106 | Stimulation of carnitine palmitoyltransferase 1 improves renal function and attenuates tissue damage after ischemia/reperfusion |
| Q47775932 | Testosterone Protects High Fat/Low Carbohydrate Diet Induced Non-Alcoholic Fatty Liver Disease in Castrated Male Rats Mainly via Modulating ER Stress |
| Q28550253 | Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01 |
| Q34035763 | The CPT1C 5'UTR contains a repressing upstream open reading frame that is regulated by cellular energy availability and AMPK |
| Q48146067 | The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions. |
| Q91710527 | The Impacts of Herbal Medicines and Natural Products on Regulating the Hepatic Lipid Metabolism |
| Q35793233 | The Origin and Diversity of Cpt1 Genes in Vertebrate Species |
| Q28552063 | The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice |
| Q51769132 | The carnitine system and cancer metabolic plasticity. |
| Q37867697 | The mechanistic basis for the induction of hepatic steatosis by xenobiotics |
| Q43087892 | The supplementation of L-carnitine does not promote alterations in the resting metabolic rate and in the use of energetic substrates in physically active individuals |
| Q37329538 | Therapeutic options in other metabolic myopathies |
| Q40425971 | Thermal instability of compound variants of carnitine palmitoyltransferase II and impaired mitochondrial fuel utilization in influenza-associated encephalopathy |
| Q91728118 | Transcriptional profiling of skeletal muscle reveals starvation response and compensatory growth in Spinibarbus hollandi |
| Q37309700 | Transgenic Adipose-specific Expression of the Nuclear Receptor RORα Drives a Striking Shift in Fat Distribution and Impairs Glycemic Control. |
| Q64906645 | Unrecognized High Occurrence of Genetically Confirmed Hereditary Carnitine Palmitoyltransferase II Deficiency in an Austrian Family Points to the Ongoing Underdiagnosis of the Disease. |
| Q37405427 | Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice |
| Q30515723 | Variants in CPT1A, FADS1, and FADS2 are Associated with Higher Levels of Estimated Plasma and Erythrocyte Delta-5 Desaturases in Alaskan Eskimos |
| Q43849983 | Whey protein isolate counteracts the effects of a high-fat diet on energy intake and hypothalamic and adipose tissue expression of energy balance-related genes |
| Q42361165 | circRNA_0046367 Prevents Hepatoxicity of Lipid Peroxidation: An Inhibitory Role against Hepatic Steatosis. |
| Q51186779 | miR-148a and miR-17-5p synergistically regulate milk TAG synthesis via PPARGC1A and PPARA in goat mammary epithelial cells. |
Search more.